Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine - Concepedia

Concepedia

Publication | Open Access

Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine

DOI Full Paper Access

555

Citations

34

References

2014

Year

Lawrence M. Gelbert, Shufen Cai, Xi Lin, Concepción Sánchez‐Martínez, Miriam Del Prado, Marı́a José Lallena, Raquel Torres, Rose T. Ajamie, Graham N. Wishart, Robert Steven Flack,

Investigational New Drugs

References

	Year	Citations

Page 1